NFSG
SRNE

Newbridge Financial Services Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Newbridge Financial Services Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,650
Closed -$2.39K – 1467
2023
Q1 		$2.39K Hold
6,650
– – ﹤0.01% 1174
2022
Q4 		$5.89K Hold
6,650
– – ﹤0.01% 1032
2022
Q3 		$10K Hold
6,650
– – 0.01% 898
2022
Q2 		$13K Hold
6,650
– – 0.01% 795
2022
Q1 		$15K Sell
6,650
-750
-10% -$2.34K 0.01% 823
2021
Q4 		$34K Sell
7,400
-12,925
-64% -$80.2K 0.02% 579
2021
Q3 		$155K Buy
20,325
+2,275
+13% +$19.3K 0.1% 203
2021
Q2 		$175K Buy
18,050
+1,000
+6% +$7.96K 0.11% 195
2021
Q1 		$141K Sell
17,050
-5,500
-24% -$58.1K 0.1% 207
2020
Q4 		$154K Sell
22,550
-4,350
-16% -$34.9K 0.13% 169
2020
Q3 		$300K Buy
+26,900
New +$246K 0.3% 75

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.31B AUM 26.51% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.27B AUM 31.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $403M AUM 22.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.68B AUM
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return

Newbridge Financial Services Group's SRNE Position: Q2 2023 in Review

Newbridge Financial Services Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2023, closing a stake of 6,650 shares — an estimated $2.39K sold.

Newbridge Financial Services Group first reported a position in SRNE in Q3 2020 and held it in 11 quarters. The position peaked at $300K in Q3 2020. 9 funds tracked by Wall St. Rank hold SRNE as of Q2 2023.

  • Newbridge Financial Services Group reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 6,650 Sorrento Therapeutics, Inc. shares in Q2 2023, an estimated $2.39K.
  • Newbridge Financial Services Group first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 11 quarters.
  • Newbridge Financial Services Group's Sorrento Therapeutics, Inc. position peaked at $300K in Q3 2020.
  • 9 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2023.

Based on Newbridge Financial Services Group's 13F filing for Q2 2023, filed 21 Jul 2023.